a { text-decoration: none; color: #464feb; } tr th, tr td { border: 1px solid #e6e6e6; } tr th { background-color: #f5f5f5; }

Carl David D’Ruiz stands as a distinguished authority at the intersection of sunscreen photoprotection, OTC drug modernization, and risk‑based safety science, bringing more than three decades of leadership in advancing consumer health and regulatory progress. Renowned for his pivotal role in shaping U.S. sunscreen policy, he has guided complex FDA OTC submissions and consistently championed science‑led regulatory frameworks that unlock safer, more effective UV filters and usher in the next generation of skincare innovation.

In his current role with dsm‑firmenich—and previously as Chair of the Personal Care Products Council (PCPC) Sunscreen Consortium—Carl has been instrumental in elevating sun‑safety advocacy across Congress, federal agencies, and leading medical societies. His work has driven meaningful transformation in the field, accelerating the adoption of non‑animal testing methodologies, modernizing toxicological approaches, and embedding sustainability standards that collectively strengthen patient safety and enhance consumer protection.

A graduate of Yale University with a Master of Public Health, Carl maintains deep engagement within the scientific community. He is a full member of the Society of Toxicology, contributes to the Scientific Affairs Committee of the Society of Cosmetic Chemists, and serves on the Board of the Photodermatology Society. As an adjunct member of the American Academy of Dermatology and an active contributor to numerous scientific and professional organizations, he continues to influence the evolution of photoprotection and advance the frontier of evidence‑based skincare innovation.